Theravance Biopharma
TBPH
TBPH
105 hedge funds and large institutions have $1.32B invested in Theravance Biopharma in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 18 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
3% less funds holding
Funds holding: 108 → 105 (-3)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
47% less call options, than puts
Call options by funds: $1.52M | Put options by funds: $2.86M
Holders
105
Holding in Top 10
2
Calls
$1.52M
Puts
$2.86M
Top Buyers
| 1 | +$114M | |
| 2 | +$28.3M | |
| 3 | +$23.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$22.9M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$21M |
Top Sellers
| 1 | -$9.54M | |
| 2 | -$6.07M | |
| 3 | -$4.49M | |
| 4 |
Millennium Management
New York
|
-$2.6M |
| 5 |
Morgan Stanley
New York
|
-$1.32M |